The FDA's position hasn't changed in decades: if it isn't documented, it didn't happen. But documentation isn't just regulatory theater—it's the mechanism through which pharmaceutical companies prove their products are safe, effective, and consistently manufactured.
For early-stage companies, the temptation is to defer document control until "later." This is a mistake. The discipline you build now determines whether your eventual compliance program is a foundation or a retrofit. Companies that establish proper practices early scale efficiently; companies that don't spend exponentially more remediating preventable gaps.
The ALCOA+ Standard
Every pharmaceutical record must satisfy ALCOA+ principles—the bedrock of Good Documentation Practices. These aren't guidelines; they're the criteria against which auditors evaluate your documentation system.
Attributable. Every entry must identify who performed the action and when. Unsigned records, shared logins, and undated entries fail this requirement fundamentally.
Legible. Records must be readable throughout their retention period. Handwritten entries must be clear; electronic records must remain accessible as formats evolve.
Contemporaneous. Data must be recorded at the time of the activity, not reconstructed afterward. Backdated entries are data integrity violations regardless of accuracy.
Original. Records must represent the first capture of information. Transcription introduces error opportunities and raises questions about what the original showed.
Accurate. Entries must reflect what actually occurred, recorded correctly the first time. Corrections must preserve the original entry while clearly documenting what changed and why.
The "plus" extends these principles: records must be Complete (no omissions), Consistent (aligned with related documentation), Enduring (preserved intact through retention periods), and Available (retrievable when needed).
Document Hierarchy
Structure your documentation system around functional levels. Quality manuals and policies occupy the apex—high-level statements of commitment and regulatory approach. Standard Operating Procedures form the second tier: stepwise instructions for routine activities. Work instructions and forms provide operational detail. Records constitute the evidence that procedures were followed.
Priority SOPs for any pharmaceutical operation include document control itself, training management, deviation handling, change control, corrective and preventive action, and equipment maintenance. These six SOPs govern your ability to manage every other document and process.
Version Control Architecture
Using obsolete documents is among the most common FDA citations. Prevent it through rigorous version control.
Adopt a naming convention that embeds critical metadata: document type, owning department, sequential number, and version. A document named SOP-QA-001-v2.1 immediately communicates that it's a Quality Assurance standard operating procedure, the first in sequence, currently at major version 2 with minor revision 1.
Major versions indicate substantive changes affecting how work is performed. Minor versions capture clarifications, corrections, and formatting updates that don't alter operational requirements. This distinction matters: major version changes typically trigger retraining requirements.
Maintain clear document states: Draft, Under Review, Approved, Effective, and Obsolete. Only Effective documents may be used for regulated work. The moment this boundary blurs—the moment anyone uses a Draft SOP to execute a batch—your document control system has failed.
Approval Workflow Discipline
Every document requires appropriate review and approval before implementation. The workflow is straightforward: authors create or revise content, reviewers verify accuracy and completeness, approvers authorize implementation. What matters is segregation: authors cannot approve their own work.
Define approval authority by document type. Quality SOPs typically require QA authorship and director-level approval. Manufacturing procedures need operational authorship with QA approval oversight. Batch records require operator completion with QA release authority. Document these authorities in your Document Control SOP.
Approvals must capture identity, date, and meaning. An approver signs not just that they saw the document, but what their signature represents: "I approve this document for implementation" communicates something different than "I have reviewed this document."
Controlled Distribution
Controlled copies are tracked and updated when documents change. Uncontrolled copies are snapshots—useful for reference but dangerous if mistaken for current versions.
Maintain a distribution log documenting who holds which controlled copies. When new versions become effective, retrieve or destroy obsolete copies and distribute replacements. Uncontrolled copies distributed for training or external reference must be clearly marked with date, version, and "UNCONTROLLED" designation.
Infrastructure Decisions
Early-stage companies can establish compliant practices without specialized software. Organize shared storage around document categories with clear separation between Draft, Effective, and Obsolete states. Configure permissions so that Effective documents are view-only for most users—only Document Control can move documents between states.
When manual tracking consumes significant QA time, when document volumes exceed reliable manual management, when regulatory milestones approach—these signals indicate that purpose-built document management infrastructure has become necessary.
Periodic Review Requirements
Documents don't remain valid indefinitely. SOPs should be reviewed every two to three years, or whenever underlying processes change. Policies may extend to three-to-five-year cycles. Forms require review when their parent SOPs change.
Establish proactive notification: Document Control alerts owners sixty days before review deadlines. Owners confirm continued accuracy or initiate revision. If content remains current, Document Control updates the review date and resets the cycle. Missed reviews create audit findings.
Retention Obligations
Pharmaceutical records must remain accessible for legally mandated periods. Batch records must be retained for at least one year beyond product expiry. Training records persist for employment duration plus years afterward. Validation documentation remains active throughout equipment or process life.
Secure storage against fire, water, unauthorized access, and format obsolescence. Test retrieval from archives periodically—backup systems that can't restore are worthless.
The Operational Reality
Document control isn't glamorous work. It's repetitive, detail-oriented, and rarely urgent until something goes wrong. But it's the backbone of pharmaceutical quality—the system that ensures products are made correctly and that you can prove it.
Companies that build proper foundations now operate efficiently later. Companies that defer document discipline until inspections loom spend years remediating gaps that proper early practice would have prevented.
Ready to systematize your document control? Contact PharmaDoc to learn how purpose-built infrastructure automates version control, approval workflows, and compliance tracking.